The intra tumoral/peritumoral ratio of CD8+ Granzyme B+ cells and density of intra-tumoral CD8+ CTLs is higher in patients with disease control than in those with progressive disease, revealing the importance of elevating tumor-killing T cells in UM. This evidence concerns the gene GZMB and neoplasm.